Skip to main content
OpenTrials
Completed

NCT Number: NCT02127554

Long Term Results and Complications After Epistaxis Treatment

The aim of this study is to find the most agreeable and in the long term most efficient treatment for epistaxis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Nosebleed (Epistaxis) - Posterior or Anterior Epistaxis Hemorrhage Nose Diseases Otorhinolaryngologic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory

Age range

14 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Zurich University Hospital

Zurich, Canton of Zurich, 8091, Switzerland

About this study

In the general population epistaxis occurs quite frequently. Approximately 60% of persons will be affected once in their lifetime, and 6% thereof will seek medical advice. Thereby anterior and posterior epistaxis are discerned. Anterior epistaxis is usually located at the Locus Kisselbachii, while posterior bleeds are found further back in the nose. There, most bleeds will originate from the A. sphenopalatina or the A. ethmoidalis.

Different treatment modalities exist. Anterior epistaxis are usually easier to treat than posterior ones. The aim of this study is to find the most efficient treatment. This involves the assessment of long term results and potential sequelae. Existing data will be complemented with information about recurrences and complications. The question is: Which treatment method leads to the least numbers of recurrences in the long term with the fewest long term sequelae?

Secondly, the most agreeable, least painful treatment method is to be identified. Therefore we will send out questionnaires to patients that were treated between March 29, 2007 and April 1st, 2008 at the Zurich University Hospital.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients treated during the study period with known address and who did not decease in the meantime.

Exclusion criteria

Insufficiently filled out questionnaires; Obvious lack of ability to remember (as tested by control questions); Known mental disability

Treatment and study plan

Primary outcomes

  1. Number of patients without recurrence

    Time frame: Up to 8 years post-treatment

Secondary outcomes

  1. Discomfort caused by treatment

    Time frame: Up to 1 day post-treatment

Other outcomes

  1. Number of complications due to treatment

    Time frame: Up to 8 years post-treatment

  2. Sequelae due to treatment

    Time frame: Up to 8 years post-treatment

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Langzeitresultate Und Komplikationen Nach Einer Epistaxisbehandlung

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Apr 30, 2014
Registry last updated
Dec 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.